TL;DR
Helius Medical Technologies, distinct from the Solana infrastructure firm Helius Labs, announced an oversubscribed private investment in public equity offering, signaling its entry into the growing sector of crypto-native treasury companies. Alongside Pantera Capital and Summer Capital, other notable investors including Big Brain Holdings, Animoca Brands, FalconX, and Arrington Capital joined the funding round. The offering, expected to close around September 18, aims to deploy proceeds into a SOL-focused treasury strategy.
The company’s plan emphasizes building an initial SOL position and gradually scaling it over the next 12-24 months. By doing so, Helius seeks to optimize staking and decentralized finance opportunities under a conservative risk framework.
This positions the firm as a key player in bridging traditional capital markets with high-yield blockchain assets. The treasury will also explore partnerships with emerging DeFi protocols to expand potential returns, while maintaining rigorous governance standards.
Solana was chosen for its ability to support high-frequency transactions, broad user adoption, and a 7% native staking yield, which facilitates productive treasury management. Pantera Capital founder Dan Morehead described Solana as a “category-defining blockchain” that can support a new financial system. Helius’s strategy is designed to increase access to the Solana ecosystem for both retail and institutional participants, while fostering deeper engagement with the blockchain’s rapidly expanding network.
The leadership team brings extensive expertise in crypto and traditional finance, including Summer Capital founder Joseph Chee, Pantera General Partner Cosmo Jiang, and Morehead as a strategic advisor. Helius shares will continue trading on Nasdaq under the ticker HSDT, with the new treasury strategy taking effect immediately. The company also committed to transparency on holdings and active participation in Solana-related initiatives, and it plans regular reports on staking performance and treasury growth to assure investors of ongoing prudence.
Helius Medical Technologies joins other corporate Solana holders like Forward Industries, Multicoin Capital, Galaxy Digital, and Jump Crypto, collectively demonstrating a significant accumulation of SOL by publicly traded treasury companies. This trend reflects growing confidence in Solana’s long-term potential as both a productive asset and a foundational blockchain for emerging financial services.
Also read: Solana (SOL) Price Eyes $300 as Galaxy Digital Buys 1.2 Million SOL
